Pirfenidone Archives - Medical Conferences

Pirfenidone may alleviate disease burden in DRCB

Presented By

Ms Helen Hicks, University of Michigan, MI, USA

Conference

ATS 2024

Type

News article

11 June 2024 11:11

Antifibrotic therapy may slow down FVC decline in RAILD

Presented By

Prof. Ivan Rosas, Baylor College of Medicine, TX, USA

Trial

Phase 2, TRAIL1

Conference

ERS 2022

Type

Peer-reviewed article

30 October 2022 22:11

Patients with RA-associated interstitial lung disease benefit from antifibrotic agent

Presented By

Prof. Joshua J. Solomon, National Jewish Health, CO, USA

Trial

Phase 2, TRAIL1

Conference

ACR 2021

Type

Peer-reviewed article

14 January 2022 10:59

Rheumatoid arthritis and interstitial lung disease: a deadly combination

Presented By

Prof. Joan Bathon, Columbia University, USA

Conference

ACR 2020

Type

Peer-reviewed article

18 January 2021 10:59

Interstitial lung disease in rheumatic diseases and systemic sclerosis

Presented By

Dr Jan Grutters, University Medical Center Utrecht, the Netherlands

Trial

SENSCIS, INPULSIS, SLS-2

Conference

EULAR 2019

Type

Peer-reviewed article

4 September 2019 23:50

IPF introduction and Pentraxin-2

Presented By

Prof. Ganesh Raghu, University of Washington, USA

Conference

ERS 2018

Type

Peer-reviewed article

7 November 2018 23:13

Novel systemic sclerosis drugs: an overview of what might be to come

Trial

Phase 3, RESOLVE-1

Conference

EULAR 2018

Type

Peer-reviewed article

24 August 2018 23:46